Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Dec 17;7(1):210-5.
doi: 10.1102/1470-7330.2007.0030.

Cytoreductive surgery in ovarian cancer

Christophe Pomel  1 , Arjun Jeyarajah, David Oram, John Shepherd, David Milliken, Jacques Dauplat, Karina Reynolds
Affiliations
Review

Cytoreductive surgery in ovarian cancer

Christophe Pomel et al. Cancer Imaging. .

Abstract

As the overall prognosis for patients with ovarian cancer is poor, the management of this condition should be restricted to expert multi-disciplinary teams in gynaecological oncology. Apparent early stage ovarian cancer requires accurate and complete staging so that potential sites for metastases are not missed. Omitting adequate staging may have significant consequences including a negative impact on survival rates in young patients. The challenge with advanced ovarian cancer is to obtain a detailed appreciation of the extent of disease. This information allows treatment with primary chemotherapy if the cancer is considered to be inoperable and/or the general condition of the patient renders her unfit for appropriate surgery. Available data would suggest that a 5-year survival rate of 50% is only possible for those patients who have had complete cytoreduction of all tumour. Therefore, the best surgical option for patients with advanced ovarian cancer is a 'complete' primary surgical procedure that achieves complete clearance of the abdominal cavity rather than 'optimal' surgery that leaves tumour nodules up to 1 cm in diameter in situ in the patient.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Laparoscopic picture showing a diffuse carcinosis infiltrating the mesentery but respecting most of the serosa of the small bowel.
See this image and copyright information in PMC

References

    1. Young RC, Walton LA, Elleberg SS, et al. Adjuvant therapy in stage 1 and stage Il epithelial ovarian cancer. Results of two prospective randomized trials. N Engl J Med. 1990;322:1021–7. - PubMed
    1. Berek JS. Practical gynecologic oncology. Baltimore, MD: Williams and Wilkins; 1988. Epithelial ovarian cancer; pp. 327–64.
    1. Averette HE, Hoskins W, Nguyen HN, et al. National survey of ovarian carcinoma. A patient care evaluation study of the American College of Surgeons. Cancer. 1993;71(suppl 4):1629–38. - PubMed
    1. Mayer AR, Chambers SK, Graves E, et al. Ovarian cancer staging: does it require a gynecologic oncologist ? Gynecol Oncol. 1992;47:223–7. - PubMed
    1. Trimbos JB, Vergote I, Bolis G, et al. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial. J Natl Cancer Inst. 2003;95:113–25. - PubMed